Detalhe da pesquisa
1.
N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
Int J Cancer
; 154(10): 1857-1868, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212892
2.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972660
3.
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.
Gastroenterology
; 164(1): 72-88.e18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108710
4.
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(12): 1399-1410, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039993
5.
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
N Engl J Med
; 382(20): 1894-1905, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32402160
6.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Hepatology
; 76(4): 1000-1012, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313048
7.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver Int
; 43(3): 695-707, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577703
8.
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).
Future Oncol
; 19(38): 2505-2516, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671641
9.
Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV.
Qual Life Res
; 32(2): 401-411, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35996039
10.
How do (false) positively screened patients experience a screening programme for liver cirrhosis or fibrosis in Germany? A qualitative study.
Health Expect
; 26(5): 1923-1930, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334867
11.
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis.
Mediators Inflamm
; 2023: 9930902, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38077228
12.
Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications.
Int J Mol Sci
; 24(14)2023 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511628
13.
Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment.
Medicina (Kaunas)
; 59(5)2023 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37241098
14.
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
J Hepatol
; 76(3): 681-693, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34801630
15.
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma.
J Hepatol
; 76(4): 862-873, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902530
16.
Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL.
J Hepatol
; 77(3): 695-701, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35472313
17.
Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2.
Oncologist
; 27(12): e938-e948, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190331
18.
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population.
Clin Gastroenterol Hepatol
; 20(11): 2567-2576.e6, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34971806
19.
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.
Liver Int
; 42(11): 2538-2547, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986902
20.
Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis.
Health Qual Life Outcomes
; 20(1): 23, 2022 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135582